CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced that financial results for the year ended December 31, 2011 will be released before the market opens on Wednesday, March 14, 2012. The Verastem management team will host a conference call discussing the company’s financial results, recent developments and management’s outlook for 2012 on Wednesday, March 14, 2012 at 4:00 p.m. (ET). The call can be accessed by dialing 1-866-383-8108 five minutes prior to the start of the call and providing the passcode 67932059. A replay will be available approximately two hours after the completion of the call and can be accessed by dialing 1-888-286-8010 and providing the passcode 13404354. The replay will be available for two weeks from the date of the live call.
